Valuation: Camurus AB

Market Cap 33B 3.42B 2.99B 2.76B 2.55B 4.84B 326B 4.92B 12.96B 161B 12.85B 12.57B 553B P/E 2026 *
36.2x
P/E 2027 * 22.5x
Enterprise Value 28.55B 2.96B 2.59B 2.39B 2.21B 4.19B 282B 4.26B 11.21B 139B 11.12B 10.88B 478B EV / Sales 2026 *
10.2x
EV / Sales 2027 * 7.24x
Free-Float
67.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.82%
1 week-3.23%
Current month-1.95%
1 month+2.88%
3 months+7.77%
6 months-18.28%
Current year-9.98%
1 week 546.5
Extreme 546.5
586
1 month 505
Extreme 505
590.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 272.2
Extreme 272.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
02-27Sell

Chief Executive Officer

1,500 0.0025%
02-27Sell

Chief Executive Officer

55,550 0.0928%
02-27Sell

Chief Executive Officer

9,950 0.0166%
Change 5-day change 1-year change 3-year change Capi.($)
+0.82%-3.23%-17.85%+100.33% 3.42B
-2.33%-2.09%+49.88%+169.76% 1,060B
-0.82%-2.30%+63.79%+62.56% 619B
-0.73%-4.98%+28.91%+83.79% 438B
+0.33%-1.17%+31.07%+26.57% 333B
-0.02%-2.85%+29.15%+46.14% 282B
-3.89%-11.22%+22.81%+25.23% 267B
+0.66%-1.42%-26.59%-37.67% 218B
-0.06%-2.88%+23.07%+61.02% 196B
-3.72%-1.10%+18.41%+69.98% 161B
Average -0.98%-3.32%+22.27%+60.77% 357.73B
Weighted average by Cap. -1.31%-3.10%+36.70%+83.67%

Financials

2026 *2027 *
Net sales 2.8B 290M 254M 234M 216M 411M 27.71B 418M 1.1B 13.65B 1.09B 1.07B 46.92B 3.76B 391M 342M 315M 291M 552M 37.24B 561M 1.48B 18.35B 1.47B 1.43B 63.07B
Net income 906M 93.97M 82.19M 75.81M 70.02M 133M 8.96B 135M 356M 4.41B 353M 345M 15.18B 1.45B 150M 131M 121M 112M 212M 14.33B 216M 569M 7.06B 564M 552M 24.27B
Net Debt -4.45B -461M -404M -372M -344M -652M -44.01B -663M -1.75B -21.68B -1.73B -1.69B -74.53B -5.74B -595M -521M -480M -443M -841M -56.76B -856M -2.25B -27.96B -2.23B -2.19B -96.12B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
308
Date Price Change Volume
10/07/26 SEK 554.50 +0.82% 101,864
09/07/26 SEK 550.00 -1.52% 95,389
08/07/26 SEK 558.50 -3.37% 76,734
07/07/26 SEK 578.00 -0.26% 76,010
06/07/26 SEK 579.50 +1.13% 92,409
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
554.50SEK
Average target price
768.12SEK
Spread / Average Target
+38.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock